Is retinol illegal in the EU? Retinol-equivalent limits explained

Direct answer

No. Retinol is not broadly illegal in European Union cosmetics. Commission Regulation (EU) 2024/996 restricts three named vitamin A ingredients: Retinol, Retinyl Acetate, and Retinyl Palmitate. The maximum is 0.05% retinol equivalent in body lotion and 0.3% retinol equivalent in other leave-on and rinse-off cosmetic products.

From 1 November 2025, cosmetic products containing those substances and not complying with the conditions could no longer be newly placed on the Union market. Qualifying products placed earlier may continue to be made available until 1 May 2027. This is a restriction with a transition, not a declaration that every retinol product became illegal overnight.

What changed

The EU regulation added the named forms of vitamin A to Annex III of the Cosmetics Regulation. Annex III is a restricted-substances list: ingredients can be used only under the specified product, concentration, and labeling conditions.

The rule followed a revised Scientific Committee on Consumer Safety opinion. The committee concluded that vitamin A in cosmetics was safe at 0.05% RE in body lotion and 0.3% RE in other leave-on and rinse-off products, while also considering total exposure to vitamin A from food, supplements, and cosmetics.

Why “retinol equivalent” matters

Retinol, retinyl acetate, and retinyl palmitate do not have identical molecular weights. A label percentage for one cannot be treated as the same vitamin A contribution as the same weight percentage of another. Retinol equivalent expresses them on a shared retinol basis.

Using the equivalence factors cited in the scientific and regulatory record, a simplified single-ingredient conversion is:

For example, 0.20% retinyl acetate contributes approximately 0.174% RE using a factor of 0.872. A formula containing more than one named form must consider their combined contribution. This arithmetic illustrates the concept; it is not a substitute for a responsible person’s safety assessment, specification records, analytical controls, or legal review.

The required warning

For cosmetic products containing Retinol, Retinyl Acetate, or Retinyl Palmitate, the regulation requires the warning: “Contains Vitamin A. Consider your daily intake before use.” The warning reflects aggregate exposure context. It should not be rewritten as proof that normal topical use is toxic or that the product treats vitamin deficiency.

A current EU package may therefore look different even when the nominal retinol percentage is familiar. Brands may lower a concentration, reformulate with another ingredient, change the product category, or update the warning and responsible-person documentation.

The two transition dates

The regulation uses the same supply-chain distinction seen in other EU product transitions:

• 1 November 2025: non-compliant products could no longer be placed on the Union market.
• 1 May 2027: non-compliant products can no longer be made available on the Union market under the transition.

“Placed” generally concerns first supply on the Union market. “Made available” includes later commercial supply. This allows previously placed stock to move through distribution for a limited period. A consumer cannot establish the legal placement date merely by seeing a high percentage on a retailer page.

Does this include retinal?

The Annex III entry names Retinol, Retinyl Acetate, and Retinyl Palmitate. Retinal, also called retinaldehyde, is not one of those three INCI names in that entry. That narrow observation should not be turned into medical advice or a claim that retinal is an unregulated loophole.

Other cosmetic safety, claims, product-information, and responsible-person obligations still apply. A substance can also fall under future amendments or another legal category. Prescription tretinoin and other medicinal retinoids are not ordinary cosmetic ingredients and follow medicine law rather than this cosmetic concentration table.

What the rule says about safety

The SCCS limit is a population-level regulatory conclusion under modeled cosmetic exposure. It does not guarantee that every individual will tolerate a product at the maximum. Retinoids can cause dryness, redness, peeling, stinging, and irritation, especially with frequent use or a crowded active routine.

Conversely, the existence of a maximum does not mean lower percentages are ineffective. Product stability, vehicle, packaging, use frequency, application amount, study endpoint, and adherence influence performance. A 0.1% product cannot be declared three times worse than a 0.3% product from concentration alone.

European Union, Northern Ireland, and Great Britain

The rule applies to the EU market and, under the Windsor Framework’s cosmetics arrangements, to Northern Ireland. Great Britain operates a separate cosmetic regime. A brand can choose to harmonize a formula across Europe and Great Britain, but that does not make the EU amendment automatically identical to GB law.

Consumers should identify the intended market from the responsible-person address and package. A retailer may display a product photo from another region, and product names can remain the same across reformulations.

What to check on a bottle

1. Find the exact INCI name: Retinol, Retinyl Acetate, or Retinyl Palmitate.
2. Check whether the brand discloses a percentage and whether it is expressed as ingredient concentration or retinol equivalent.
3. Identify whether the product is body lotion or another leave-on/rinse-off category.
4. Look for the vitamin A warning on a current EU package.
5. Confirm the intended market, batch, directions, and responsible-person information.
6. Do not infer a lawful concentration from ingredient order; retinoids can appear inside the reorderable portion of the list.

What users should do with the information

The regulation is not a personalized routine schedule. Follow the current product directions, introduce retinoids cautiously, use daytime sun protection, and avoid interpreting irritation as proof that a product is working. Pregnancy, breastfeeding, prescription retinoids, diagnosed conditions, or significant reactions require individualized guidance from a qualified professional.

Droplet’s retinol guide explains routine fit, while the ingredient checker can identify the named form on a pasted label. It cannot verify the manufacturer’s quantitative formula or certify regulatory compliance.

Why the viral “ban” framing fails

“The EU banned retinol” compresses a product-category limit, three named ingredients, a shared equivalence calculation, warning text, and two transition dates into a false binary. It also encourages consumers to treat another retinoid name as automatically stronger, safer, or outside all regulation.

The more accurate answer is less dramatic and more useful: the EU set concentration limits for the combined vitamin A contribution of three cosmetic ingredients, with a lower body-lotion limit and a staged market transition. Product fit and personal tolerance remain separate questions.

A combined retinol-equivalent example

Suppose a hypothetical face serum contains 0.20% retinol and 0.10% retinyl palmitate. A compliance calculation does not simply add the label percentages and call the result 0.30% retinol equivalent. Each named material contributes vitamin A according to the applicable equivalence factor and purity information, then those contributions are combined. The legal annex and supporting technical documentation, not a viral conversion chart, determine the relevant calculation.

That distinction becomes more important when a brand reports a supplier blend rather than the pure retinoid amount. “1% retinol complex” might describe a blend containing a much smaller retinol fraction. Conversely, a low-looking ester percentage cannot be compared with retinol without converting to the common RE basis. Droplet will not infer either value from marketing language.

Consumers can use a transparent example to understand the concept, but manufacturers and responsible persons need formula records, raw-material specifications, purity data, category classification, and current legal advice. This article is not a compliance calculator.

Warning text and transition dates

The amendment includes the warning “Contains Vitamin A. Consider your daily intake before use” for products containing the restricted substances. The warning is a population-level risk-management measure concerning aggregate vitamin A exposure; it is not a statement that normal topical use is equivalent to taking a supplement.

The transition is staged. Under Regulation 2024/996, products not complying with the new conditions could continue to be placed on the Union market until 1 November 2025 and made available until 1 May 2027. That means legacy stock can coexist with newly aligned stock during the transition. Check the current consolidated law and the exact package market rather than using a social post's publication date as a legal cutoff.

How to compare retinoid products without a false hierarchy

Do not rank retinol, retinal, retinyl esters, or prescription retinoids using percentage alone. Different molecules, conversion steps, vehicles, stability systems, dosing directions, and evidence bases make raw percentages non-equivalent. The EU amendment discussed here names retinol, retinyl acetate, and retinyl palmitate; it should not be generalized into a universal potency table for every retinoid.

A better comparison records the exact form, disclosed finished-product amount and basis, product category, directions, packaging, supporting clinical evidence, and personal response. The regulation answers a market-compliance question. It does not answer which retinoid, if any, is appropriate for an individual's routine.

Retinal and other retinoids

The amendment's vitamin A entry should be read by named substance, not by the broad marketing family “retinoids.” Retinal, hydroxypinacolone retinoate, prescription tretinoin, adapalene, and other materials are not automatically covered by the same three-name concentration calculation merely because online content groups them together. They may be governed by other cosmetic, medicines, safety, or claims requirements.

That is not a loophole-shopping invitation. A different molecule has different evidence, stability, conversion, irritation, use, and legal questions. Replacing retinol with a fashionable derivative does not establish equal benefit at a smaller percentage or exemption from every rule.

Retail and marketplace checks

Product pages often retain old percentages, images, or warning text after a formula transition. Verify the physical package's market and batch, then compare it with the responsible person's current disclosure. A listing that ships across borders may display an EU image while supplying a GB or US unit.

For a dated research record, save the listing URL, access date, package image, size, exact claim wording, and any manufacturer response. Do not declare a product “illegal” from a stale image or an ingredient-order estimate. Regulators and responsible persons assess the actual formula, category, placement date, labeling, and supply chain.

Source notes

• EUR-Lex: Commission Regulation (EU) 2024/996
• European Commission SCCS: Revised scientific opinion on Vitamin A
• ECHA: Current Annex III restriction entry for Retinol
• GOV.UK: Cosmetics regulation in Northern Ireland

Sources and regulatory status were checked on August 14, 2026.